Inventor · Rancho Santa Fe, CA, US

Andrew A. Young

69Patents
30h-index
43Co-inventors
88Inventor score

Filing activity: Jan 10, 1991 → Nov 30, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6858576B1 Methods for regulating gastrointestinal motility Human Necessities 131 Expired
US6902744B1 Exendin agonist formulations and methods of administration thereof Human Necessities 126 Expired
US6872700B1 Methods for glucagon suppression Human Necessities 117 Expired
US6924264B1 Modified exendins and exendin agonists Human Necessities 107 Expired
US6703359B1 Inotropic and diuretic effects of exendin and GLP-1 Human Necessities 104 Expired
US7297761B2 Pharmaceutical compositions containing exendins Human Necessities 95 Expired
US7521423B2 Exendin pharmaceutical compositions Human Necessities 84 Expired
US7153825B2 Methods for glucagon suppression using modified exendins Human Necessities 84 Expired
US7115569B2 Exendins, exendin agonists, and methods for their use Human Necessities 83 Expired
US7741269B2 Exendins and exendin agonists for weight reduction and obesity Human Necessities 81 Active
US7138375B2 Use of exendins and agonists thereof for lowering plasma lipid Human Necessities 75 Expired
US8288338B2 Exendin and exendin agonists for eating disorders Human Necessities 61 Active
US7928065B2 Methods of treatment using exendin peptides or GLP-1 peptides Human Necessities 61 Active
US7442680B2 Inotropic and diuretic effects of GLP-1 and GLP-1 agonists Human Necessities 59 Expired
US6114304A Methods for regulating gastrointestinal motility Human Necessities 58 Expired
US8263545B2 GIP analog and hybrid polypeptides with selectable properties Human Necessities 57 Active
US5234906A Hyperglycemic compositions Human Necessities 48 Expired
US8445647B2 Modified exendins and exendin agonists Human Necessities 48 Active
US7419952B2 Use of exendins and agonists thereof to treat diabetes Human Necessities 45 Expired
US7691963B2 Exendins and exendin agonists modified with polyamino acids Human Necessities 42 Active
US8026210B2 Exendins and exendin agonist analogs to regulate gastrointestinal motility Human Necessities 42 Active
US7700549B2 Exendin agonist analogs to treat diabetes Human Necessities 42 Active
US7608692B2 Exendins and exendin agonists modified with albumin Human Necessities 41 Active
US7683030B2 Methods of treating diabetes with albumin-conjugated exendin peptides Human Necessities 40 Active
US8057822B2 Modified exendins and exendin agonists Human Necessities 40 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.